rfxcel will be at the Healthcare Distribution Alliance’s (HDA) 2020 Distribution Management Conference and Expo March 8-11 at the Marriott Marquis San Diego Marina (in San Diego, of course). We’re an official sponsor, and invite you to stop by Booth #103 to meet our team and learn the latest from the industry’s leader in supply chain traceability, environmental monitoring, and analytics!
We’re especially excited to talk about the Drug Supply Chain Security Act (DSCSA) Saleable Returns Verification requirement and the solution to meet it: the Verification Router Service (VRS). rfxcel and Vantage Solutions will present a report on our FDA pilot to “Quantify the Readiness of the VRS Network.” Join us on Monday, March 9, from 2:15-3:15 p.m., for an educational discussion about how we’re applying lessons learned from our pilot.
The deadline for meeting the Saleable Returns Verification and being able to authenticate and verify saleable returns using the VRS is November 27, so it’s crucial to be ready. See more about this below!
What to Expect at the HDA Conference
The annual gathering is HDA’s largest supply chain education event. This year, as many as 600 industry-leading manufacturers, distributors, consultants, and third parties are expected to attend the immersive “deep dive” into critical healthcare supply chain topics. But it’s not only a forum to engage in operational and strategic discussions — it’s a great networking event.
The HDA will also be presenting two prestigious awards, its Distribution Management Award (DMA) and the DMA for Industry Leadership. The DMA honors HDA member companies’ “efforts to improve the efficiency, effectiveness, and safety of the healthcare supply chain through successful trading partner initiatives that enhance processes, reduce costs, and leverage advanced technologies or logistical practices.” rfxcel won the award in 2018. The DMA for Industry Leadership recognizes an individual who has “valued and greatly enhanced trading partner relationships, contributed to the development of industry knowledge, and has actively participated within his/her company and through HDA to advance the state of the industry.”
rfxcel Is Sponsoring Must-Hear Discussions!
You won’t be able to miss us at this year’s conference. In addition to our VRS presentation with Vantage Solutions on Monday (2:15-3:15 p.m.) and our exhibit at Booth #103, we’re a sponsor of the following key supply chain discussions:
Monday, March 9
- Intro to DSCSA
- DSCSA Saleable Returns Verification Industry Update
- Serialization Pilot Reports
- Serialization Pilot Reports 2
Tuesday, March 10
- DSCSA FDA Activity Update
- Traceability Dispenser Panel
- Traceability Roundtables
Get the Latest on the DSCSA VRS and rfxcel’s FDA-Approved VRS Pilot!
rfxcel is the industry thought leader in VRS. We extended the testing of VRS and have been implementing a pilot program for the FDA since June 2019 to quantify the readiness of the VRS network to meet the DSCSA Saleable Returns Requirement.
The HDA initiated the VRS with feedback from the pharma industry. It’s an automated service that verifies if a Product Identifier (PI) is valid. A PI has four components: a Global Trade Item Number (GTIN), a unique serial number, a lot ID, and an expiration date. There are multiple VRS providers, each responsible for determining if a specific group of PIs is valid. Thanks to VRS, everyone in the pharmaceutical supply chain can exchange data quickly and securely and verify a product’s validity for sale. Ultimately, this will promote the safety of patients and consumers, and ensure the authenticity of products.
Our FDA-approved pilot is structured to enable transparency and open testing. A key and unique aspect of the pilot is that we will share the details of our VRS test cases with all VRS providers to ensure they have a common detailed set of test cases. We’ll work with the providers to verify the test conditions to enable maximum readiness of the VRS network across all VRS providers. We published a draft copy of our interim findings at the HDA Traceability Seminar in Washington, D.C., in October 2019 and provided our final interim report to the FDA shortly afterwards. We’ll submit a final report to the FDA by the end of the year.
As we said above, companies have until November 27 to meet the DSCSA Saleable Returns Verification requirement and to be able to authenticate and verify saleable returns using the VRS. Through our FDA pilot and by applying our expertise in supply chain track and trace, serialization, and compliance solutions, we are helping the pharma industry prepare for this deadline.
The 2020 Distribution Management Conference and Expo is the perfect place to talk with our supply chain experts and learn everything you need to know about the VRS — as well as all the other exciting things going on at rfxcel. We’ve released the latest version of our award-winning rfxcel Traceability System (rTS 7.0). We’re continuing to blaze trails in track and trace, environmental monitoring, and worldwide compliance. And we’re growing our teams worldwide, from Russia to the Middle East to Asia. Book an appointment now (or just stop by Booth #103) and be sure to attend our VRS presentation with Vantage Solutions. We look forward to seeing you!